MedTrace Logo

Alerta Cannabis: Evaluation of Web-based Tailored Intervention

NCT05849636 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1850

Last updated 2023-05-09

No results posted yet for this study

Summary

This study consists in the the design, implementation, and evaluation of the first web-based computer tailored intervention program aimed at the prevention of cannabis use in Spanish adolescents (ALERTA CANNABIS). A Cluster Randomized Controlled Trial is conducted to test the effectiveness of ALERTA CANNABIS in students aged 14 to 18 years across 34 high schools from Andalusia (southern Spain), which are randomized either to the experimental or the control condition (EC and CC).

Conditions

  • Cannabis Use
  • Adolescent Behavior
  • E-health

Interventions

BEHAVIORAL

ALERTA CANNABIS

The intervention consists of preventive messages about the benefits of not consuming cannabis, reducing the positive attitudes and encouraging the negative attitudes towards cannabis use, as well as social influence and self-efficacy, by personalized feedback. Skills and action plans are encouraged to help the student to reject cannabis use. This information is presented through different tailored messages. In addition, the participants will be able to choose avatars to accompany them during the intervention. The intervention consists of a short story about the cannabis use by adolescents.The stories take place in three different scenarios (at home, at school leaving, and in public places).

Sponsors & Collaborators

  • Ministerio de Ciencia, Innovación y Universidades

    collaborator UNKNOWN

  • Maastricht University

    collaborator OTHER

  • University of Seville

    lead OTHER

Principal Investigators

  • Marta Lima Serrano · University of Seville

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05849636 on ClinicalTrials.gov